Joel Hedgpeth
Director/Board Member bij CompleGen, Inc.
Profiel
Joel Hedgpeth is currently the Director at CompleGen, Inc. He previously held positions as the Chief Scientific Officer at Epoch Biosciences, Inc. and Berlex Biosciences.
Dr. Hedgpeth obtained an undergraduate degree from The University of California, San Francisco.
Actieve functies van Joel Hedgpeth
| Bedrijven | Functie | Begin |
|---|---|---|
CompleGen, Inc.
 CompleGen, Inc. Pharmaceuticals: MajorHealth Technology CompleGen, Inc. provides HTS assays to the pharmaceutical, biopharmaceutical, and agchem industries. The company was founded by Joel Hedgpeth and John Swindle in 2000 and is headquartered in Seattle, WA. | Director/Board Member | 06-03-2012 |
Eerdere bekende functies van Joel Hedgpeth
| Bedrijven | Functie | Einde |
|---|---|---|
Epoch Biosciences, Inc.
 Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Chief Operating Officer | 01-01-2002 |
| Berlex Biosciences | Chief Operating Officer | 01-01-1993 |
Opleiding van Joel Hedgpeth
| The University of California, San Francisco | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Health Technology |
CompleGen, Inc.
CompleGen, Inc. Pharmaceuticals: MajorHealth Technology CompleGen, Inc. provides HTS assays to the pharmaceutical, biopharmaceutical, and agchem industries. The company was founded by Joel Hedgpeth and John Swindle in 2000 and is headquartered in Seattle, WA. | Health Technology |
| Berlex Biosciences |
